Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiha M Long

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Infection and Immunity|April 16, 2014
Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier functionTiha M Long, Shahista Nisa, Michael S Donnenberg, et al.
Seminars in Cell & Developmental Biology|May 25, 2015
Conceptual barriers to understanding physical barriersAmulya Lingaraju, Tiha M Long, Yitang Wang, et al.
Cancer Immunology Research|November 11, 2017
Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating LymphocytesLucas A Horn, Tiha M Long, Ryan Atkinson, et al.
Inflammatory Bowel Diseases|April 10, 2013
RNase-L deficiency exacerbates experimental colitis and colitis-associated cancerTiha M Long, Arindam Chakrabarti, Heather J Ezelle, et al.
Neurology Open Access|February 20, 2026
Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis PatientsJiwon Oh, Robert J Fox, Douglas Lorne Arnold, et al.
Molecular Cancer Therapeutics|November 29, 2023
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate CancerLynda Bennett, Praveen Kumar Jaiswal, Ryan V Harkless, et al.
Molecular Cancer Therapeutics|April 22, 2017
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer GrowthJacob Kach, Tiha M Long, Phillip Selman, et al.
Molecular Cancer Research : MCR|September 2, 2018
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma TumorsIsabel Romero-Calvo, Christopher R Weber, Mohana Ray, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Infection and Immunity|April 16, 2014
Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier functionTiha M Long, Shahista Nisa, Michael S Donnenberg, et al.
Seminars in Cell & Developmental Biology|May 25, 2015
Conceptual barriers to understanding physical barriersAmulya Lingaraju, Tiha M Long, Yitang Wang, et al.
Cancer Immunology Research|November 11, 2017
Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating LymphocytesLucas A Horn, Tiha M Long, Ryan Atkinson, et al.
Inflammatory Bowel Diseases|April 10, 2013
RNase-L deficiency exacerbates experimental colitis and colitis-associated cancerTiha M Long, Arindam Chakrabarti, Heather J Ezelle, et al.
Neurology Open Access|February 20, 2026
Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis PatientsJiwon Oh, Robert J Fox, Douglas Lorne Arnold, et al.
Molecular Cancer Therapeutics|November 29, 2023
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate CancerLynda Bennett, Praveen Kumar Jaiswal, Ryan V Harkless, et al.
Molecular Cancer Therapeutics|April 22, 2017
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer GrowthJacob Kach, Tiha M Long, Phillip Selman, et al.
Molecular Cancer Research : MCR|September 2, 2018
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma TumorsIsabel Romero-Calvo, Christopher R Weber, Mohana Ray, et al.
Pageof 1